Taking people in PolandPhase 1
Tests MK-1084 in adults with advanced solid tumors carrying KRAS mutations
Tests MK-1084 in adults with advanced solid tumors that have KRAS mutations.
Plain-language title generated from the registry record
Registry title: Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors
Key facts
- Where
- Gdansk, Koszalin, Poznan, and Warsaw, PolandSee the 4 sites
- Phase
- Phase 1
Where in Poland
- Uniwersyteckie Centrum KliniczneGdansk, PolandTaking people
- Szpital Wojewodzki im. Mikolaja Kopernika w KoszalinieKoszalin, PolandTaking people
- Uniwersytecki Szpital Kliniczny w PoznaniuPoznan, PolandTaking people
- Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut BadawczyWarsaw, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Merck Sharp & Dohme LLC
- Trial code
- NCT05067283EU 2022-501563-40-00
- Record updated
- 30 October 2026